乐经科,关健伟

• 1:广东深圳市第五人民医院神经内科

摘要(Abstract)：

<正>脑卒中是人类死亡的三大病因之一,在我国其已成为第一大致残和第三致死病因。同时,其高发病率、高致残率、高病死率和高复发率是当代医学特别是神经科学亟须解决的课题。现代医学已证实约1/3的脑卒中是由颈动脉狭窄、栓子脱落所致。因此,治疗颈动脉狭窄已成为预防缺血性脑卒中的重要措施之一。随着人类对该疾病认识的不断深入和

关键词(KeyWords)： 血管内支架形成术;颈动脉狭窄;应用;展望

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 乐经科,关健伟

参考文献(References)：

• [1]Goldstein LB,Adams R,Alberts MJ,et al.Primary preven-tion of ischemic stroke:a guideline from the AHA/ASA coun-cil[J].Stroke,2006,37:1 583-1 633.
• [2]American College of Cardiology Foundation,American Societyof Interventional&Therapeutic Neuroradiology,Society forCardiovascular Angiography and Interventions,et al.ACCF/SCAI/SVMB/ASITN 2007 clinical expert consensus documenton carotid stenting:a report of the American College of Cardi-ology Foundation Task Force on Clinical Expert ConsensusDocuments[J].J Am Cardiol,2007,49:126-170.
• [3]Yadav JS,Wholey MH,Kuntz RE,et al.Protected carotid-ar-tery stenting versus endarterectomy in high risk patients[J].NEngl J Med,2004,351:1 493-1 501.
• [4]CaRESS Steering Committee.Carotid Revascularization UsingEndarterectomy or Stenting Systems(CaRESS)phaseⅠclini-cal trial:1-year results[J].J Vasc Surg,2005,42:213-219.
• [5]White CJ,Iyer SS,Hopkins LN,et al.Carotid stenting withdistal protection in high surgical risk patients:the BEACH tri-al 30 day results[J].Catheter Cardiovasc Interv,2006,67:503-5 812.
• [6]Gray WA,Yadav JS,Verta P,et al.The CAPTURE Regis-try:predictors of outcomes in carotid artery stenting with em-bolic protection for high surgical risk patients in the early post-approval setting[J].Catheter Cardiovasc Interv,2007,70:1025-1 033.
• [7]Hopkins LN,Myla S,Grube E,et al.Carotid artery revascu-larization in high surgical risk patients with NexStent and Fil-terWireEX/EZ:1-year results in the CABERNET trial[J].Catheter Cardiovasc Interv,2008,71:950-960.
• [8]Wiesmann M,Schopf V,Jansen O,et al.Stent protected an-gioplasty versus carotid endarterectomy in patients with carotidartery stenosis:meta-analysis of randomized trialdata[J].EurRadiol,2008,18:2 956-2 966.
• [9]Jeng JS,Liu HM,Tu YK.Carotid angioplasty with or withoutstenting versus carotid endarterectomy for carotid artery steno-sis:a meta-analysis[J].J Neurol Sci,2008,270:40-47.
• [10]Brahmanandam S,Ding EL,Conte MS,et al.Clinical resultsof carotid artery stenting compared with carotid endarterectom[J].J Vasc Surg,2008,47:343-349.
• [11]Qureshi AI,Kirmani JF,Hussein HM,et al.Early and in-terme-diate-term outcomes with drug-eluting stents in high-risk patients with symptomatic intracranial stenosis[J].Neu-rosurgery,2006,59(5):1 044-1 051.
• [12]White CJ,Iyer SS,Hopkins LN,et al.Carotid stenting withdis-tal protection in high surgical risk patients:the BEACHtrial 30 dayresults[J].Catheter Cardiovasc Interv,2006,67(4):503-512.
• [13]Iyer SS,White CJ,Hopkins LN,et al.Carotid artery revascu-larization in high-surgical-risk patients using the CarotidWALL-STENT and FilterWire EX/EZ:1-year outcomes inthe BEACH Pivotal Group[J].J Am Coll Cardiol,2008,51(4):427-434.
• [14]Iyer V,de Donato G,Deloose K,et al.The type of embolicpro-tection does not influence the outcome in carotid arterystenting[J].J Vasc Surg,2007,46(2):251-256.
• [15]El-Koussy M,Schroth G,Do DD,et al.Periprocedural embolicevents related to carotid artery stenting detected by diffusion-weighted MRI:comparison between proximal and distal embo-lus protection devices[J].J Endovasc Ther,2007,14(3):293-303.
• [16]Theiss W,Hermanek P,Mathias K,et al.Predictors of deathand stroke after carotid angioplasty and stenting:a subgroupanalysisof the Pro-CAS data[J].Stroke,2008,39:2 325-2330.
• [17]Howard VJ,Voeks JH,Lutsep HL,et al.Does sex matter30-day stroke and death rates after carotid artery stenting inwomen versus men:results from the CREST lead-in phase[J].Stroke,2009,40:1 140-1 147.